Live Breaking News & Updates on Protein Expression Facility

Stay updated with breaking news from Protein expression facility. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

PATH and University of Queensland create custom proteins for malaria diagnostics


Share
A global health organisation and state-of-the-art laboratory at The University of Queensland are collaborating to support the development and evaluation of point-of-care diagnostics for malaria with new custom-made proteins.
PATH and UQ’s Protein Expression Facility will supply researchers with malaria proteins to improve point-of-care diagnostic tools and help reduce the burden of malaria, which continues to affect more than 200 million people and cause more than 400,000 deaths each year.
Director of UQ’s Protein Expression Facility Professor Linda Lua said the partnership would help malaria researchers develop new diagnostic tools.
“New tools to enable the development of highly sensitive diagnostics are urgently needed to reduce disease and death attributable to malaria,” Professor Lua said. ....

Gonzalo Domingo , Linda Lua , Diagnostics Program , University Of Queensland , Melinda Gates Foundation , Protein Expression Facility , Expression Facility , Professor Linda Lua , Scientific Director , Melinda Gates , கோன்சலோ டொமிஂகொ , லிண்டா லூ , பரிசோதனை ப்ரோக்ர்யாம் , பல்கலைக்கழகம் ஆஃப் குயின்ஸ்லாந்து , மெலிண்டா வாயில்கள் அடித்தளம் , ப்ரோடீந் வெளிப்பாடு வசதி , வெளிப்பாடு வசதி , ப்ரொஃபெஸர் லிண்டா லூ , அறிவியல் இயக்குனர் , மெலிண்டா வாயில்கள் ,

COVID-19 Vaccine Corporation Partners With The University Of Queensland


Tuesday, 23 February 2021, 1:10 pm
AUCKLAND: COVID-19 Vaccine Corporation (CVC) has joined
forces with the University of Queensland in its vaccine
production efforts.
After halting development of its
spike protein based candidate in December, CVC continues to
progress development of its proprietary T-cell
vaccine.
Its T-cell vaccine is designed to work with
other existing vaccines in order to improve efficacy,
lengthen immunity time and to protect against all new
variants for the SARS-Cov-2 virus, including those from
Britain and South Africa.
CVC’s efforts and new
partnership are particularly timely in the wake of South
African government’s attempt to recall a million doses of ....

South Africa , United Kingdom , South African , Robert Feldman , Balaji Somasundaram , Linda Lua , Citizen Community , Foundation For Public Interest Journalism , University Of Queensland , Vaccine Corporation , Vaccine Corporation Partners , Vaccine Corporation On Infopages , Polybatics Ltd , Protein Expression Facility , Executive Dr Robert , Operations Manager Dr Balaji Somasundaram , Professor Linda Lua , Scoop Citizen Community , In Depth Engaged Journalism , Scoop Foundation , Public Interest Journalism , Covid 19 Vaccine Corporation , Health Care Industry , Medi Cal , Tertiary Education , ஒன்றுபட்டது கிஂக்டம் ,

Business Scoop » COVID-19 Vaccine Corporation Partners With The University Of Queensland


Press Release – COVID-19 Vaccine Corporation
AUCKLAND: COVID-19 Vaccine Corporation (CVC) has joined forces with the University of Queensland in its vaccine production efforts. After halting development of its spike protein based candidate in December, CVC continues to progress development …
AUCKLAND: COVID-19 Vaccine Corporation (CVC) has joined forces with the University of Queensland in its vaccine production efforts.
After halting development of its spike protein based candidate in December, CVC continues to progress development of its proprietary T-cell vaccine.
Its T-cell vaccine is designed to work with other existing vaccines in order to improve efficacy, lengthen immunity time and to protect against all new variants for the SARS-Cov-2 virus, including those from Britain and South Africa. ....

South Africa , United Kingdom , South African , Robert Feldman , Balaji Somasundaram , Linda Lua , University Of Queensland , Vaccine Corporation , Polybatics Ltd , Press Release , Protein Expression Facility , Executive Dr Robert , Operations Manager Dr Balaji Somasundaram , Professor Linda Lua , New Zealand , ஒன்றுபட்டது கிஂக்டம் , ராபர்ட் ஃபெல்ட்மந் , பாலாஜி சோமசுந்தரம் , லிண்டா லூ , பல்கலைக்கழகம் ஆஃப் குயின்ஸ்லாந்து , தடுப்பூசி நிறுவனம் , ப்ரெஸ் வெளியீடு , ப்ரோடீந் வெளிப்பாடு வசதி , நிர்வாகி டாக்டர் ராபர்ட் , செயல்பாடுகள் மேலாளர் டாக்டர் பாலாஜி சோமசுந்தரம் , ப்ரொஃபெஸர் லிண்டா லூ ,